XNCR Q4 2019 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-69.6% YoY

Gross Profit

-$24M-677.6% margin

Operating Income

-$31M-869.5% margin

Net Income

-$27M-765.4% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

-83.8%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$23M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$670M

Total Liabilities

$77M

Stockholders' Equity

$593M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$12M	-69.6%
Gross Profit	-$24M	-$16M	-53.1%
Operating Income	-$31M	-$21M	-45.0%
Net Income	-$27M	-$18M	-47.9%

Revenue Segments

Royalty

$3M71%

Collaboration

$1M31%

Milestone

-$100,000-3%